Deciphex is an Ireland-based company that develops software products offering digital pathology solutions for clinical and research applications.
$32.1M
Jan 06, 2025
-
Ability Biologics is a Canada-based biotechnology company that researches and develops antibody therapeutics for the treatment of cancer and autoimmune diseases.
$6M
Jun 17, 2024
-
Wheeler Bio is an Oklahoma-based CDMO that offers services such as drug development, transient protein production, and preclinical material testing for the healthcare sector.
$31M
Apr 16, 2023
-
IvexSol is a Massachusetts-based biotechnology company that develops and manufactures technology-driven viral vectors for the healthcare industry.
$23.8M
Jan 25, 2023
-
Wheeler Bio is an Oklahoma-based CDMO that offers services such as drug development, transient protein production, and preclinical material testing for the healthcare sector.
$31M
Oct 02, 2022
-
Frequently Asked Questions about Charles River
What is Charles River investing in?
Charles River has invested in 12 companies including Deciphex, Ability Biologics and Wheeler Bio
What company did Charles River invest in?
Charles River invested in a total 12 companies including Deciphex, Ability Biologics and Wheeler Bio
What are the top 5 investments by Charles River?
The top companies in which Charles River invested are Deciphex, Ability Biologics, Wheeler Bio, IvexSol and Wheeler Bio
